Skip to main content
. 2022 Dec 28;229:70–80. doi: 10.1016/j.ijbiomac.2022.12.284

Table 2.

Various nanobodies, their sources, and mechanism of action against SARS-CoV-2.

Sl. No. Nanobodies Source Dissociation constant (KD) value (nM) against protein of SARS-CoV-2 Mechanism of action Reference
1. Ty1 Alpaca Targets the RBD of the Spike protein with a greater affinity. [74], [75]
2. H-11 D4 Ilama 39 (±2) Blocks the attachment of the ACE2 receptor with the Spike protein [74], [76], [77]
3. H-11 H4 Ilama 12 (±1.5) Blocks the attachment of the ACE2 receptor with the Spike protein. [74], [76], [77]
4. Sb23 Library of synbodies 10.6 (± 2) Blocks the interaction of the ACE2 receptor and the RBD [78], [79]
5. K-874A Camels (no modifications are included) 1.4 Inhibits the fusion of the viral membrane and prevents viral replication [80]
6. Nb11–59 Pichia pastoris 21.6 Blocks the interaction of the ACE2 receptor and the RBD [28], [81]
7. Nb16–68 36
8. VNAR Sharks 38.5–60.3 Targets the S1-RBD and breaks the salt bridge between ACE2 and RBD [82], [83]
9. n3113.1-Fc 5.3 Binds to the RBD of the Spike protein without involving ACE2 receptor [84]